PIK3CA mutations in endometrial carcinomas in Chinese women: Phosphatidylinositol 3′-kinase pathway alterations might be associated with favorable prognosis

Human Pathology

Volumn 43, Issue 8, 2012, Pages 1197-1205

  Dong, Ying ^a   Yang, Xi ^a   Wong, Oscar ^b   Zhang, Xiaoming ^a   Liang, Ying ^a   Zhang, Ying ^a   Wong, Wei ^a   Nong, Lin ^a   Liao, Qinping ^a   Li, Ting ^a  

^a PEKING UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chinese women; Endometrial carcinomas; PI3K AKT pathway alteration; PIK3CA mutations; Prognosis

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; PIK3CA PROTEIN; PROGESTERONE RECEPTOR; PROTEIN KINASE B; PROTEIN P53; SERINE; TENSIN; THREONINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CHINESE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DNA SEQUENCE; ENDOMETRIUM CARCINOMA; ENZYME ACTIVATION; EXON; FEMALE; GENE EXPRESSION; GENE LOSS; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; PREMENOPAUSE; SEQUENCE ANALYSIS; SURVIVAL TIME;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, ENDOMETRIOID; DISEASE-FREE SURVIVAL; DNA MUTATIONAL ANALYSIS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84863987220     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2011.08.021     Document Type: Article

References (26)

1. P.G. Rose Endometrial carcinoma N Engl J Med 335 1996 640 649 (Pubitemid 26277956)
2. H.B. Salvesen, S.L. Carter, and M. Mannelqvist Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation Proc Natl Acad Sci U S A 106 2009 4834 4839
3. D. Llobet, J. Pallares, and A. Yeramian Molecular pathology of endometrial carcinoma: practical aspects from the diagnostic and therapeutic viewpoints J Clin Pathol 62 2009 777 785
4. N. Samarnthai, K. Hall, and I.T. Yeh Molecular profiling of endometrial malignancies Obstet Gynecol Int 2010 162363
5. I. Vivanco, and C.L. Sawyers The phosphatidylinositol 3-kinase AKT pathway in human cancer Nat Rev Cancer 2 2002 489 501 (Pubitemid 37328931)
6. Y. Samuels, Z. Wang, and A. Bardelli High frequency of mutations of the PIK3CA gene in human cancers Science 304 2004 554 (Pubitemid 38541907)
7. Y. Samuels, and K. Ericson Oncogenic PI3K and its role in cancer Curr Opin Oncol 18 2006 77 82 (Pubitemid 43740454)
8. N. Terakawa, Y. Kanamori, and S. Yoshida Loss of PTEN expression followed by Akt phosphorylation is a poor prognostic factor for patients with endometrial cancer Endocr Relat Cancer 10 2003 203 208 (Pubitemid 36758649)
9. K. Uegaki, Y. Kanamori, and J. Kigawa PTEN-positive and phosphorylated-Akt-negative expression is a predictor of survival for patients with advanced endometrial carcinoma Oncol Rep 14 2005 389 392
10. L. Catasus, A. Gallardo, M. Cuatrecasas, and J. Prat PIK3CA mutations in the kinase domain (exon 20) of uterine endometrial adenocarcinomas are associated with adverse prognostic parameters Mod Pathol 21 2008 131 139 (Pubitemid 351172164)
11. L. Catasus, A. Gallardo, M. Cuatrecasas, and J. Prat Concomitant PI3K-AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis Mod Pathol 22 2009 522 529
12. L. Catasus, E. D'Angeld, and C. Pons Expression profiling of 22 genes involved in the PI3K-AKT pathway identifies two subgroups of high-grade endometrial carcinomas with different molecular alterations Mod Pathol 23 2010 694 702
13. D. Konstantinova, R. Kaneva, and R. Dimitrov Rare mutations in the PIK3CA gene contribute to aggressive endometrial cancer DNA Cell Biol 29 2010 65 70
14. F.J. Esteva, H. Guo, and S. Zhang PTEN, PIK3CA, p-AKT, and p-p70S6K status: association with trastuzumab response and survival in patients with HER2-positive metastatic breast cancer Am J Pathol 177 2010 1647 1656
15. M. Bogusiewicz, A. Semczuk, and M. Gogacz Lack of correlation between leptin receptor expression and PI3-K/Akt signaling pathway proteins immunostaining in endometrioid-type endometrial carcinomas Cancer Lett 238 2006 61 68 (Pubitemid 43851145)
16. K. Oda, D. Stokoe, Y. Taketani, and F. McCormick High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma Cancer Res 65 2005 10669 10673 (Pubitemid 41713332)
17. M.P. Hayes, H. Wang, and R. Espinal-Witter PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia Clin Cancer Res 12 2006 5932 5935 (Pubitemid 44703751)
18. M.P. Hayes, W. Douglas, and L.H. Ellenson Molecular alterations of EGFR and PIK3CA in uterine serous carcinoma Gynecol Oncol 113 2009 370 373
19. S. Barbi, I. Cataldo, and G. De Manzoni The analysis of PIK3CA mutations in gastric carcinoma and meta-analysis of literature suggest that exon-selectivity is a signature of cancer type J Exp Clin Cancer Res 29 2010 32
20. K. Oda, J. Okada, and L. Timmerman PIK3CA cooperates with other phosphatidylinositol 3′-kinase pathway mutations to effect oncogenic transformation Cancer Res 68 2008 8127 8136
21. K.M. Vasudevan, D.A. Barbie, and M.A. Davies AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer Cancer Cell 16 2009 21 32
22. C.J. Creighton, X. Fu, and B.T. Hennessy Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer Breast Cancer Res 12 2010 R40
23. E. Tokunaga, E. Oki, and Y. Kimura Coexistence of the loss of heterozygosity at the PTEN locus and HER2 overexpression enhances the Akt activity thus leading to a negative progesterone receptor expression in breast carcinoma Breast Cancer Res Treat 101 2007 249 257 (Pubitemid 46169878)
24. B. Saffari, L.A. Jones, and A. el-Naggar Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival Cancer Res 55 1995 5693 5698
25. C.D. Rolitsky, K.S. Theil, and V.R. McGaughy HER-2/neu amplification and overexpression in endometrial carcinoma Int J Gynecol Pathol 18 1999 138 143 (Pubitemid 29153280)
26. P. Dong, Z. Xu, and N. Jia Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway Mol Cancer 8 2009 103